Therapeutic dose assessment of patient switching from atorvastatin to simvastatin.

The American journal of managed care

Volumn 13 Suppl 3, Issue , 2007, Pages

  Hess, Gregory ^a   Sanders, Kafi N ^a   Hill, Jerrold ^a   Liu, Larry Z ^a  

^a Surveillance Data Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; GENERIC DRUG; HEPTANOIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PYRROLE DERIVATIVE; SIMVASTATIN;

ARTICLE; HEALTH CARE QUALITY; HUMAN; PHARMACOKINETICS; RETROSPECTIVE STUDY; UNITED STATES;

DRUGS, GENERIC; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; PYRROLES; QUALITY OF HEALTH CARE; RETROSPECTIVE STUDIES; SIMVASTATIN; THERAPEUTIC EQUIVALENCY; UNITED STATES;

EID: 34547822507     PISSN: None     EISSN: 19362692     Source Type: Journal    
DOI: None     Document Type: Article

References (0)